Bellevue Asset Management AG - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Asset Management AG ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$8,851,000
+8.0%
81,640
-14.7%
1.35%
+0.9%
Q3 2015$8,199,000
+6.6%
95,730
+25.6%
1.34%
+25.3%
Q2 2015$7,688,000
+7.0%
76,190
-18.2%
1.07%
+6.5%
Q1 2015$7,184,00093,1601.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders